Skin self-examinations (SSEs) for the detection of primary or recurrent melanomas may be an effective surveillance strategy. The protocol design for a randomized, controlled trial to assess such a program was published in Trials.
Archive | Clinical Trials
Trial Designed to Evaluate Efficacy of an SSE Melanoma Screening Campaign
Posted in Melanoma News, Health Professionals, Clinical Trials
Immunotherapy combination shows benefit for patients with advanced melanoma, phase 3 trial shows
A combination of two drugs that target different proteins on immune system T cells kept advanced melanoma in check significantly longer than one of the drugs alone in a phase 3 clinical trial involving 714 patients.
Posted in Melanoma News, Health Professionals, Clinical Trials
Frontline Tebentafusp Significantly Improves OS in Metastatic Uveal Melanoma
Tebentafusp (IMCgp100) resulted in a highly significant and clinically meaningful improvement in overall survival (OS) when given as a frontline treatment in patients with metastatic uveal melanoma…
Posted in Melanoma News, Health Professionals, Clinical Trials
Tebentafusp improves OS in advanced uveal melanoma
Tebentafusp significantly prolonged OS compared with immune checkpoint inhibitors and other standard therapies among previously untreated patients with metastatic uveal melanoma, results of a randomized phase 3 study showed.
Posted in Melanoma News, Health Professionals, Clinical Trials
